Skip to navigation Skip to content Skip to subnav
Searching 2017-2018 Session

2017-2018 Session

Change Session
Select a session

2007-2008 and Earlier Sessions

S.92 (Act 193)

An act relating to prescription drug price transparency and cost containment

Sen. Virginia Lyons, Sen. Christopher Pearson , Sen. Claire Ayer, Sen. Brian Campion, Sen. Ann Cummings, Sen. Michael Sirotkin
5/30/2018 - Signed by Governor on May 30, 2018
Sponsor(s)
Last Recorded Action
Senate 5/30/2018 - Signed by Governor on May 30, 2018
Bill/Resolution Text
Other Text

NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.

An act relating to prescription drug price transparency and cost containment

Detailed Status

2017-2018 Legislative Session
Body Date Journal Calendar Location Full Status
No activity found for S.92 in the 2017-2018 Legislative Session.

Back to top

Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.

An act relating to prescription drug price transparency and cost containment

Committee Meetings

2017-2018 Legislative Session
Meeting Date Committee
An act relating to prescription drug price transparency and cost containment

Meeting Full List

2017-2018 Legislative Session
Thursday, March 2, 2017
Committee(s):
Senate Committee on Health and Welfare
11:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Charles Storrow, Express Scripts, Inc.
Bonita Libman, Professor of Medicine, University of Vermont Medical Center
Jessa Barnard, General Counsel and Vice-President for Policy, Vermont Medical Society
Thomas Felix, Medical Director, R& D Policy, Amgen

Tuesday, March 14, 2017
Committee(s):
Senate Committee on Health and Welfare
-

S.92 - An act relating to prescription drug price transparency and cost containment

Jason Williams, Director of Government and Community Relations, University of Vermont Medical Center

Wednesday, March 15, 2017
Committee(s):
Senate Committee on Health and Welfare
10:15 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
Matt McMahon, Lobbyist, McLean, Meehan & Rice
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, March 17, 2017
Committee(s):
Senate Committee on Health and Welfare
8:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, March 30, 2017
Committee(s):
House Committee on Health Care
3:15 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Walk-through

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, March 16, 2018
Committee(s):
House Committee on Health Care
1:00 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Tuesday, April 3, 2018
Committee(s):
House Committee on Health Care
1:00 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Jessa Barnard, Executive Director, Vermont Medical Society
Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
Jim McKay, Director of Clinical Development and Medical Affairs, Sandoz
Carrie Phillips, Executive Officer, Vermont Board of Pharmacy
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Matt McMahon, Lobbyist, McLean, Meehan & Rice
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare

Friday, April 13, 2018
Committee(s):
House Committee on Health Care
1:40 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Review new draft of bill and vote

Rep. Lori Houghton
Rep. Benjamin Jickling, House Committee on Health Care
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 20, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Review House Amendment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, April 25, 2018
Committee(s):
Senate Committee on Health and Welfare
8:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Rep. Lori Houghton, House Committee on Health Care
Rep. William J. Lippert, House Committee on Health Care
Jeff Hochberg, President, Vermont Retail Druggists
Jamie Feehan, Lobbyist, CVS/Caremark
Bridget Morris, Lobbyist, Association of Accessible Medicine
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
10:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Continued Testimony and Committee Discussion

Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Jeff Hochberg, President, Vermont Retail Druggists
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association

Thursday, April 26, 2018
Committee(s):
Senate Committee on Health and Welfare
8:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Proposed Amendment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jamie Feehan, Lobbyist, CVS/Caremark
Rep. Lori Houghton, House Committee on Health Care

Thursday, April 26, 2018
Committee(s):
House Committee on Health Care
9:40 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Update, Senate actions

Rep. Lori Houghton
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 27, 2018
Committee(s):
Senate Committee on Health and Welfare
9:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Proposed Amendment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, May 2, 2018
Committee(s):
House Committee on Health Care
10:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Committee discussion, changes to various bills from the Senate; others as needed

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Thursday, May 3, 2018
Committee(s):
House Committee on Health Care
9:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Review changes; other bills as needed

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Stephanie Barrett, Associate Fiscal Officer, Joint Fiscal Office
1:00 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Committee Discussion; further amendment to S.203; vote on S.224.



An act relating to prescription drug price transparency and cost containment

Witnesses Who Testified

2017-2018 Legislative Session
House Committee on Health Care
  • Jessa Barnard, Executive Director, Vermont Medical Society
  • Stephanie Barrett, Associate Fiscal Officer, Joint Fiscal Office
  • Jennifer Carbee, Legislative Counsel, Office of Legislative Council
  • Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
  • Rep. Lori Houghton
  • Rep. Benjamin Jickling, House Committee on Health Care
  • Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
  • Jim McKay, Director of Clinical Development and Medical Affairs, Sandoz
  • Matt McMahon, Lobbyist, McLean, Meehan & Rice
  • Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
  • Carrie Phillips, Executive Officer, Vermont Board of Pharmacy
Senate Committee on Health and Welfare
  • Jessa Barnard, General Counsel and Vice-President for Policy, Vermont Medical Society
  • Jennifer Carbee, Legislative Counsel, Office of Legislative Council
  • Jamie Feehan, Lobbyist, CVS/Caremark
  • Thomas Felix, Medical Director, R& D Policy, Amgen
  • Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
  • Jeff Hochberg, President, Vermont Retail Druggists
  • Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
  • Rep. Lori Houghton, House Committee on Health Care
  • Bonita Libman, Professor of Medicine, University of Vermont Medical Center
  • Rep. William J. Lippert, House Committee on Health Care
  • Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
  • Matt McMahon, Lobbyist, McLean, Meehan & Rice
  • Bridget Morris, Lobbyist, Association of Accessible Medicine
  • Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
  • Charles Storrow, Express Scripts, Inc.
  • Jason Williams, Director of Government and Community Relations, University of Vermont Medical Center

Back to top

Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill.  The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.

No fiscal documents found for S.92 in the 2017-2018 Legislative Session.
No committee of conference data found for S.92 in the 2017-2018 Legislative Session.

Act


An act relating to prescription drug price transparency and cost containment

Statutes Affected

2017-2018 Legislative Session

Back to top

Staff & Other Information

Staff
Jennifer Carbee, Legislative Counsel

Back to top